Fig. 7
From: Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model
Effect of the T G F−β cytokine in the immunotherapy. Interval injection every 168 hours applying 106 DCs per dose during three weeks. Tumor population (green line) considering the influence of T G F−β in the model and tumor population (red line) without influence of T G F−β in the model